Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06179004 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Supraclavicular Bupivacaine Vs. Supraclavicular Liposomal Bupivacaine for Orthopedic Wrist Surgery

Study acronym: Vs
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: May 2026 to Oct 2026v6
  2. Primary and study completion dates: May 2025 to May 2026 Eligibility criteria shortened, about 1 wordv5 Show 1 more changeShow less
    • Eligibility criteria shortened, about 1 word

    See this version in full on ClinicalTrials.gov ↗

  3. Study description shortened, about 3 words Study title shortened, about 1 wordv4 Show 1 more changeShow less
    • Study title shortened, about 1 word

    See this version in full on ClinicalTrials.gov ↗

  4. Trial status: Not Yet Recruiting to Recruiting Primary and study completion dates: Dec 2024 to May 2025 · Start date changed from estimate of Feb 2024 to Apr 10, 2024 · Site details revisedv3 Show 3 more changesShow less
    • Primary and study completion dates: Dec 2024 to May 2025
    • Start date changed from estimate of Feb 2024 to Apr 10, 2024
    • Site details revised
  5. Start date: Dec 2023 to Feb 2024v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Orthopedic wrist procedures often cause significant postoperative pain. A supraclavicular nerve block is an effective and proven method to help reduce postoperative pain and decrease opioid use around the time of upper extremity surgery. Liposomal bupivacaine (Exparel) has been approved for use around the brachial plexus, but its analgesic efficacy has limited data. The investigators' goal is to evaluate the effectiveness of Exparel as compared to plain bupivacaine. The investigators hope to ensure the quality of pain control around the time of distal radius fracture repair and reduce the variability of care at the investigators institution by prospectively and rigorously collecting perioperative data during this study.
Trial Details
NCT Number NCT06179004
Lead Sponsor University of North Carolina, Chapel Hill
Conditions Distal Radius Fractures, Wrist Fractures
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov